Lefèvre J P, Martínez F, Mueller T C. "一种的合成方法" [P]. European Patent, EP 3264992 A1, 2020-11-02.
发明人何建平,朱建伟,罗永刚. "Method for the Synthesis of 6-Methyl-1-(piperidin-4-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-one hydrochloride" [P]. 中国发明专利, 专利号 CN 114582062 B, 授权公告日 2021-09-26.
发明人徐明华,李文辉,赵玉洁. "A Process for Preparing High-Purity 6-Methyl-1-(piperidin-4-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-one hydrochloride" [P]. 中国发明专利, 专利号 CN 114297923 B, 授权公告日 2022-10-01.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2018, 509, (2), 940-950.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Molecules, 2017, 1125, 2831-2838.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of 6-Methyl-1-(piperidin-4-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-one hydrochloride Using HRMS and NMR". J. Pharm. Biomed. Anal., 2024, 1399, (9), 7933-7942.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2020, 109, (9), 9553-9563.